CpG DNA in cancer immunotherapy

Current Topics in Microbiology and Immunology

Volumn 247, Issue , 1999, Pages 157-170

  Weiner, G J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANTIBODY PRODUCTION; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER THERAPY; CELLULAR IMMUNITY; CPG ISLAND; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CPG ISLANDS; HUMANS; IMMUNIZATION; IMMUNOTHERAPY; NEOPLASMS; VACCINES, DNA;

EID: 0033385269     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (11)

1. Baldridge JR, Ward JR (1997) Effective adjuvants for the induction of antigen-specific delayed type hypersensitivity. Vaccine 15:395-401
2. Dallas ZK, Rasmussen WL, Krieg AM (1996) Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 157:1840-5
3. Basse PH (1995) Tissue distribution and tumor localization of effector cells in adoptive immunotherapy of cancer. APMIS Suppl 55:1-28
4. Berinstein N, Levy R (1987) Treatment of a murine B-cell lymphoma with monoclonal antibodies and IL-2. J Immunol 139:971-976
5. Brazolot Millan CL, Weeratna R, Krieg AM, Siegrist CA, Davis HL (1998) CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci USA, 15553-8
6. Bukowski RM (1997) Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2. Cancer 80:1198-220
7. Chace JH, Hooker NA, Mildenstein KL, Krieg AM, Cowdery JS (1997) Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathology 84:185-93
8. Chen HY, Wu SL, Yeh MY, Chen CF, Mikami Y, Wu JS (1993) Antimetastatic activity induced by Clostridium butyricum and characterization of effector cells. Anticancer Research 13:107-11
9. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. Journal of Experimental Medicine 186:1623-1631
10. Cohen AD, Boyer JD, Weiner DB (1998) Modulating the immune response to genetic immunization. FASEB J 12:1611-26
11. Coley WB (1893) The treatment of malignant tumors by repeated inoculations of Erysipelas with a report of ten original cases. Am J Med Sci 105:487-511